'Molecular missing link' may explain allergic reactions to personal care products

January 03, 2020

Boston, MA -- Chemical compounds found in skin creams and other personal care products can cause an allergic reaction in the skin, a common condition known as allergic contact dermatitis (ACD). While ACD is on the rise, particularly in industrialized countries, exactly how personal care chemical compounds trigger a reaction remains unknown. Most allergic reactions involving T cells are attributed to proteins or peptide antigens that trigger the immune system. But chemical compounds found in personal care products are different kinds of molecules that were not thought to be able to directly elicit a reaction by T cells. Investigators from Brigham and Women's Hospital, Columbia University and Monash University have uncovered a new molecular mechanism by which common components of consumer products can trigger an immune response, highlighting a specific molecular connection that may explain the mystery behind these cases of ACD. The team's findings are published in Science Immunology.

"What we present here is a molecular missing link," said co-senior author D. Branch Moody, MD, a principal investigator and physician in the Brigham's Division of Rheumatology, Inflammation and Immunity. "We questioned the prevailing paradigm that T cell-mediated allergic reaction is only triggered when T cells respond to proteins or peptide antigens. We find a mechanism through which fragrance can initiate a T cell response through a protein called CD1a."

For many substances, such as those found in soaps, cosmetics, fragrances, jewelry and plants, it is unclear how a reaction by T cells is triggered. Chemical compounds found in these products were thought to be too small and of the wrong chemical structure to be detected directly by T cells, which are the immune cells that set off ACD.

The researchers, including the co-lead author Annemieke de Jong from Columbia University, wondered if there might be another explanation. The team tested whether CD1a, a molecule found in immune cells that form the outer layer of human skin, could bind directly to allergens found in personal care products and present these molecules to the immune system, triggering a reaction. First author, Sarah Nicolai, MD, a research fellow in Medicine at the Brigham, exposed T cells to material from skin patch testing kits used in allergy clinics and found that T cells responded to certain substances, including balsam of Peru, a tree oil widely used in cosmetics and toothpaste. The team further identified substances within balsam of Peru -- benzyl benzoate and benzyl cinnamate -- directly responsible for stimulating the T cell response. Investigators also tested similar substances and found a dozen small molecules, including farnesol, that appeared to elicit a response.

To further understand how these compounds triggered a reaction, investigators at Monash University solved the X-ray crystal structure, revealing that when farnesol forms a complex with CD1a, farnesol kicks out naturally occurring human lipids, making CD1a more visible to T cells and leading to T cell activation.

The authors note that while their work shows that fragrances found in personal care products can directly initiate a T cell response, further investigation is needed to understand if this causes disease and allergic reactions. To better understand this, they will need to see if patients commonly have T cells that recognize molecules like farnesol. The team is also seeking new molecules that could block the response of CD1a and override the activation of T cells. Work is currently underway to identify promising molecules.
The research was funded by grants from the National Institutes of Health (T32 AI007306, K01 AR068475, R01 AR048632), the National Health and Medical Research Council of Australia (NHMRC), and the Australian Research Council (ARC) (CE140100011); an Irving Scholarship from the Irving Institute for Clinical and Translational Research at Columbia University, and a Wellcome Trust Collaborative Award. Research reported in this publication was performed in the CCTI Flow Cytometry Core, supported in part by the Office of the Director, National Institutes of Health, under award S10OD020056.

Brigham Health, a global leader in creating a healthier world, consists of Brigham and Women's Hospital, Brigham and Women's Faulkner Hospital, the Brigham and Women's Physicians Organization and many related facilities and programs. With more than 1,000 inpatient beds, approximately 60,000 inpatient stays and 1.7 million outpatient encounters annually, Brigham Health's 1,200 physicians provide expert care in virtually every medical and surgical specialty to patients locally, regionally and around the world. An international leader in basic, clinical and translational research, Brigham Health has nearly 5,000 scientists, including physician-investigators, renowned biomedical researchers and faculty supported by over $700 million in funding. The Brigham's medical preeminence dates back to 1832, and now, with 19,000 employees, that rich history is the foundation for its commitment to research, innovation, and community. Boston-based Brigham and Women's Hospital is a teaching affiliate of Harvard Medical School and dedicated to educating and training the next generation of health care professionals. For more information, resources, and to follow us on social media, please visit brighamandwomens.org.

Brigham and Women's Hospital

Related Immune System Articles from Brightsurf:

How the immune system remembers viruses
For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

How does the immune system develop in the first days of life?
Researchers highlight the anti-inflammatory response taking place after birth and designed to shield the newborn from infection.

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.

Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.

COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.

Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.

Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.

How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

Read More: Immune System News and Immune System Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.